Menu Search
Equities

STERIS plc

STE:NYQ

STERIS plc

Actions
Health CareMedical Equipment and Services
  • Price (USD)219.19
  • Today's Change3.69 / 1.71%
  • Shares traded1.07m
  • 1 Year change+6.24%
  • Beta0.8318
Data delayed at least 15 minutes, as of Nov 09 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year STERIS plc grew revenues 13.28% from 4.54bn to 5.14bn while net income improved 253.40% from 107.03m to 378.24m.
Gross margin43.19%
Net profit margin11.09%
Operating margin16.59%
Return on assets5.45%
Return on equity9.07%
Return on investment5.95%
More ▼

Cash flow in USDView more

In 2024, STERIS plc did not generate a significant amount of cash. However, the company earned 973.27m from its operations for a Cash Flow Margin of 18.94%. In addition the company used 887.36m on investing activities and also paid 85.19m in financing cash flows.
Cash flow per share11.18
Price/Cash flow per share19.48
Book value per share64.32
Tangible book value per share2.52
More ▼

Balance sheet in USDView more

STERIS plc has a Debt to Total Capital ratio of 26.66%, a lower figure than the previous year's 46.37%.
Current ratio2.33
Quick ratio1.49
Total debt/total equity0.3644
Total debt/total capital0.2666
More ▼

Growth rates in USD

Year on year, growth in dividends per share increased 10.33% while earnings per share excluding extraordinary items fell by -0.19%. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
Div yield(5 year avg)0.87%
Div growth rate (5 year)8.83%
Payout ratio (TTM)36.21%
EPS growth(5 years)9.33
EPS (TTM) vs
TTM 1 year ago		0.4653
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.